View in EDS HTML Full Text PDF Full Text

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.

Saved in:
Bibliographic Details
Title: Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.
Authors: Horvath N; Department of Haematology, Royal Adelaide Hospital , Adelaide , Australia., Spencer A; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Kenealy M; Cabrini Health, Australia and Monash University , Melbourne , Australia., Joshua D; Department of Haematology, Royal Prince Alfred Hospital , Camperdown , Australia, and Sydney University, Sydney, Australia., Campbell PJ; Department of Haematology, Andrew Love Cancer Centre , Geelong , Australia., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital , Hwasun , Republic of Korea., Hou J; Department of Hematology, Shanghai Changzheng Hospital , Shanghai , China., Qiu L; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China., Kalff A; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Khong T; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Londhe A; Janssen Research & Development LLC , Titusville , NJ , USA., Siggins S; Janssen Cilag , Sydney , Australia., van Kooten Losio M; Janssen Cilag , Sydney , Australia., Eisbacher M; Janssen Cilag , Sydney , Australia., Prince HM; Cabrini Health, Australia and Monash University , Melbourne , Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne , Australia.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2019 Sep; Vol. 60 (9), pp. 2122-2133. Date of Electronic Publication: 2019 Feb 19.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30777794
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Horvath+N%22">Horvath N</searchLink>; Department of Haematology, Royal Adelaide Hospital , Adelaide , Australia.<br /><searchLink fieldCode="AU" term="%22Spencer+A%22">Spencer A</searchLink>; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia.<br /><searchLink fieldCode="AU" term="%22Kenealy+M%22">Kenealy M</searchLink>; Cabrini Health, Australia and Monash University , Melbourne , Australia.<br /><searchLink fieldCode="AU" term="%22Joshua+D%22">Joshua D</searchLink>; Department of Haematology, Royal Prince Alfred Hospital , Camperdown , Australia, and Sydney University, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Campbell+PJ%22">Campbell PJ</searchLink>; Department of Haematology, Andrew Love Cancer Centre , Geelong , Australia.<br /><searchLink fieldCode="AU" term="%22Lee+JJ%22">Lee JJ</searchLink>; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital , Hwasun , Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hou+J%22">Hou J</searchLink>; Department of Hematology, Shanghai Changzheng Hospital , Shanghai , China.<br /><searchLink fieldCode="AU" term="%22Qiu+L%22">Qiu L</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China.<br /><searchLink fieldCode="AU" term="%22Kalff+A%22">Kalff A</searchLink>; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia.<br /><searchLink fieldCode="AU" term="%22Khong+T%22">Khong T</searchLink>; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia.<br /><searchLink fieldCode="AU" term="%22Londhe+A%22">Londhe A</searchLink>; Janssen Research & Development LLC , Titusville , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Siggins+S%22">Siggins S</searchLink>; Janssen Cilag , Sydney , Australia.<br /><searchLink fieldCode="AU" term="%22van+Kooten+Losio+M%22">van Kooten Losio M</searchLink>; Janssen Cilag , Sydney , Australia.<br /><searchLink fieldCode="AU" term="%22Eisbacher+M%22">Eisbacher M</searchLink>; Janssen Cilag , Sydney , Australia.<br /><searchLink fieldCode="AU" term="%22Prince+HM%22">Prince HM</searchLink>; Cabrini Health, Australia and Monash University , Melbourne , Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne , Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2019 Sep; Vol. 60 (9), pp. 2122-2133. <i>Date of Electronic Publication: </i>2019 Feb 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30777794
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2019.1579322
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2122
    Titles:
      – TitleFull: Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Horvath N
      – PersonEntity:
          Name:
            NameFull: Spencer A
      – PersonEntity:
          Name:
            NameFull: Kenealy M
      – PersonEntity:
          Name:
            NameFull: Joshua D
      – PersonEntity:
          Name:
            NameFull: Campbell PJ
      – PersonEntity:
          Name:
            NameFull: Lee JJ
      – PersonEntity:
          Name:
            NameFull: Hou J
      – PersonEntity:
          Name:
            NameFull: Qiu L
      – PersonEntity:
          Name:
            NameFull: Kalff A
      – PersonEntity:
          Name:
            NameFull: Khong T
      – PersonEntity:
          Name:
            NameFull: Londhe A
      – PersonEntity:
          Name:
            NameFull: Siggins S
      – PersonEntity:
          Name:
            NameFull: van Kooten Losio M
      – PersonEntity:
          Name:
            NameFull: Eisbacher M
      – PersonEntity:
          Name:
            NameFull: Prince HM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2019 Sep
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 60
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1